2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
2006 | Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes
| EUROPEAN JOURNAL OF ENDOCRINOLOGY |
2016 | Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model
| PLOS ONE |
2007 | Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model | METABOLISM-CLINICAL AND EXPERIMENTAL |
2007 | Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS |
2017 | Diabetes self-assessment score and the development of diabetes A 10-year prospective study
| MEDICINE |
2010 | Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscle | LIPIDS |
2011 | Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model.
| DIABETES & METABOLISM JOURNAL |
2018 | Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
| SCIENTIFIC REPORTS |
2020 | Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo
| JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS |
2019 | Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
| DIABETES THERAPY |
2012 | Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction
| AUTOPHAGY |
2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
2013 | Discovery of DiPeptidyl Peptidase-4 Gene Variants and the Associations with Efficacy of Vildagliptin in Patients with Type 2 Diabetes - A Pilot Study
| JOURNAL OF DIABETES & METABOLISM |
2006 | Does birthweight predict adolescent adiponectin levels? | CLINICAL ENDOCRINOLOGY |
2008 | Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass. | CALCIFIED TISSUE INTERNATIONAL |
2016 | Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea
| PLOS ONE |
2009 | Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone | DIABETIC MEDICINE |
2014 | Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without caridiovascular event | ENDOCRINE |
2020 | Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules | DIABETES OBESITY & METABOLISM |
2020 | Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
| BIOMEDICINES |
2017 | Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study | INTERNATIONAL JOURNAL OF CANCER |
2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
2016 | Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study
| Endocrinology and Metabolism (대한내분비학회지) |
2006 | Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control | CLINICAL ENDOCRINOLOGY |
2011 | Effects of leptin and adiponectin on pancreatic β-cell function | METABOLISM-CLINICAL AND EXPERIMENTAL |
2006 | Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus | METABOLISM-CLINICAL AND EXPERIMENTAL |
2018 | Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice | INTERNATIONAL JOURNAL OF OBESITY |
2016 | Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
| PLOS ONE |
2010 | Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.
| NEPHROLOGY DIALYSIS TRANSPLANTATION |
2005 | Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes | CLINICAL PHARMACOLOGY & THERAPEUTICS |
2007 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus | CLINICAL ENDOCRINOLOGY |
2018 | Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
| Endocrinology and Metabolism (대한내분비학회지) |
2023 | Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
| DIABETES & METABOLISM |
2020 | Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study) | DIABETES OBESITY & METABOLISM |
2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
2020 | Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial | DIABETES OBESITY & METABOLISM |
2016 | Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
| MEDICINE |
2018 | Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2012 | Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance
| CARDIOVASCULAR DIABETOLOGY |
2016 | Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK | INTERNATIONAL JOURNAL OF OBESITY |
2017 | Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition | AUTOPHAGY |
2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
2011 | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | METABOLISM-CLINICAL AND EXPERIMENTAL |
2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
2013 | Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic Changes | ANNALS OF SURGICAL ONCOLOGY |
2019 | Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria | Journal of Diabetes and Its Complications |
2015 | Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes
| CARDIOVASCULAR DIABETOLOGY |
2013 | Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction | ENDOCRINOLOGY |
2011 | Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients | ACTA DIABETOLOGICA |
2015 | Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1c with Time
| BIOMED RESEARCH INTERNATIONAL |
2013 | Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
| DIABETES & METABOLISM JOURNAL |
2012 | Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
2014 | GPR30 mediates anorectic estrogen-induced STAT3 signaling in the hypothalamus | METABOLISM-CLINICAL AND EXPERIMENTAL |
2006 | Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
2017 | High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution
| Evidence-Based Medicine |
2012 | Higher morning to evening ratio in total dose of twice-daily biphasic insulin analog might be effective in achieving glucose control in patients with poorly controlled type 2 diabetes | DIABETES TECHNOLOGY & THERAPEUTICS |
2014 | HMG CoA Reductase Inhibitor Treatment Induces Dysglycemia in Renal Allograft Recipients | TRANSPLANTATION |